WALTHAM, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc. (NASDAQ:CERU), a clinical-stage company developing nanoparticle-drug conjugates (NDCs), today announced that the company is relocating its headquarters from Cambridge to the AstraZeneca Gatehouse Park BioHub in Waltham, MA effective January 1, 2016.
